Oncology News

Short-term anti-tumor necrosis factor treatment combined with surgical closure induced long-term MRI healing in patients with Crohn’s perianal fistulas more frequently than anti-TNF therapy alone, according to research.

The FDA granted fast track designation to CMG901 for treatment of certain patients with gastrointestinal cancers.

Smart Medical Systems Ltd. announced the FDA has approved its G-Eye colonoscope, based on Olympus 510(k)-cleared PCF colonoscope series.

Patients with esophageal cancer who engaged in prehabilitation exercise demonstrated improved responses to neoadjuvant chemotherapy than those who did not, according to a study published in British Journal of Sports Medicine.

Patients with a genetic predisposition for colorectal cancer could help define risk-adapted surveillance intervals after detection and removal of adenomas at colonoscopy, according to recent findings.

An artificial intelligence model showed potential for pancreatic cancer prediction, using electronic medical records to identify individuals with a 25-fold greater risk for developing the disease within 3 to 36 months, study results showed.

In a Healio video exclusive, Subhankar Chakraborty, MD, PhD, a gastroenterologist at The Ohio State University Wexner Medical Center, outlines a new initiative that aims to cut colorectal cancer screening disparities in half by 2023.

NAPLES, Florida — In this video, Jennifer L. Seminerio, MD, speaks with Healio about some of the most informative presentations at the 2022 ACG/FGS Spring Symposium.

In partnership with the Colon Cancer Coalition, Salix Pharmaceuticals launched the Faces of Blue campaign to raise awareness about the importance of colorectal cancer screening and early detection.

In partnership with the Colon Cancer Coalition, Salix Pharmaceuticals launched the Faces of Blue campaign to raise awareness about the importance of colorectal cancer screening and early detection.